194 related articles for article (PubMed ID: 17225990)
21. Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients.
Andrès E; Noel E; Kurtz JE; Henoun Loukili N; Kaltenbach G; Maloisel F
Drugs Aging; 2004; 21(7):427-35. PubMed ID: 15132711
[TBL] [Abstract][Full Text] [Related]
22. Idiosyncratic drug-induced agranulocytosis: Update of an old disorder.
Andrès E; Zimmer J; Affenberger S; Federici L; Alt M; Maloisel F
Eur J Intern Med; 2006 Dec; 17(8):529-35. PubMed ID: 17142169
[TBL] [Abstract][Full Text] [Related]
23. [Hospital readmission induced by adverse drug reaction: a pilot study in a post-emergency unit of a French university hospital].
Chayé H; Bernard M; Tubéry M; Rousseau V; Ecoiffier M; Montastruc JL; Bagheri H
Rev Med Interne; 2015 Jul; 36(7):450-6. PubMed ID: 25604839
[TBL] [Abstract][Full Text] [Related]
24. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
25. Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records.
Sun C; Zhao L; Yuan Y; Xiang Y; Liu A
Pharmacoepidemiol Drug Saf; 2023 Apr; 32(4):416-425. PubMed ID: 36305574
[TBL] [Abstract][Full Text] [Related]
26. Spironolactone-induced agranulocytosis.
Whitling AM; Pérgola PE; Sang JL; Talbert RL
Ann Pharmacother; 1997 May; 31(5):582-5. PubMed ID: 9161653
[TBL] [Abstract][Full Text] [Related]
27. Agranulocytosis and significant leucopenia with neuroleptic drugs: results from the AMUP program.
Grohmann R; Schmidt LG; Spiess-Kiefer C; Rüther E
Psychopharmacology (Berl); 1989; 99 Suppl():S109-12. PubMed ID: 2573103
[TBL] [Abstract][Full Text] [Related]
28. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors.
van Staa TP; Boulton F; Cooper C; Hagenbeek A; Inskip H; Leufkens HG
Am J Hematol; 2003 Apr; 72(4):248-54. PubMed ID: 12666135
[TBL] [Abstract][Full Text] [Related]
29. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group.
Shapiro S; Issaragrisil S; Kaufman DW; Anderson T; Chansung K; Thamprasit T; Sirijirachai J; Piankijagum A; Porapakkham Y; Vannasaeng S; Leaverton PE; Young NS
Am J Trop Med Hyg; 1999 Apr; 60(4):573-7. PubMed ID: 10348230
[TBL] [Abstract][Full Text] [Related]
30. Agranulocytosis induced by pyrithyldione, a sedative hypnotic drug.
Ibáñez L; Ballarín E; Pérez E; Vidal X; Capellà D; Laporte JR
Eur J Clin Pharmacol; 2000 Jan; 55(10):761-4. PubMed ID: 10663456
[TBL] [Abstract][Full Text] [Related]
31. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
32. Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis.
Apinantriyo B; Lekhakula A; Rujirojindakul P
Hematology; 2011 Jan; 16(1):50-3. PubMed ID: 21269568
[TBL] [Abstract][Full Text] [Related]
33. Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A; Miremont-Salamé G; Pérault-Pochat MC; Noize P; Haramburu F;
Fundam Clin Pharmacol; 2015 Feb; 29(1):106-11. PubMed ID: 24990220
[TBL] [Abstract][Full Text] [Related]
34. Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brasil.
Hamerschlak N; Montezuma MP; Bacal N; Szterling LN; Rosenfeld LG; Guerra CC
Rev Paul Med; 1993; 111(1):294-8. PubMed ID: 8235248
[TBL] [Abstract][Full Text] [Related]
35. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis.
Andrès E; Federici L; Weitten T; Vogel T; Alt M
Expert Opin Drug Saf; 2008 Jul; 7(4):481-9. PubMed ID: 18613811
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.
Maj S; Centkowski P
Med Sci Monit; 2004 Sep; 10(9):PI93-5. PubMed ID: 15328493
[TBL] [Abstract][Full Text] [Related]
37. Anti-infectives-induced adverse drug reactions in hospitalized patients.
Gholami K; Parsa S; Shalviri G; Sharifzadeh M; Assasi N
Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):501-6. PubMed ID: 15844215
[TBL] [Abstract][Full Text] [Related]
38. Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.
Bäckström M; Hägg S; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2002; 11(3):239-45. PubMed ID: 12051124
[TBL] [Abstract][Full Text] [Related]
39. Risk of drug-induced agranulocytosis: the case of calcium dobesilate.
Zapater P; Horga JF; García A
Eur J Clin Pharmacol; 2003 Mar; 58(11):767-72. PubMed ID: 12634984
[TBL] [Abstract][Full Text] [Related]
40. [Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
Zapater Hernández P; Horga de la Parte JF; García AG
An Med Interna; 2002 Jun; 19(6):275-82. PubMed ID: 12152385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
